Dr. Borad on the SARAH and SIRveNIB Studies in Hepatocellular Carcinoma

preview_player
Показать описание
Mitesh J. Borad, MD, associate professor of medicine, consultant, Division of Hematology/Oncology, Mayo Clinic, discusses the results of the SARAH and SIRveNIB studies in patients with hepatocellular carcinoma.
Рекомендации по теме